Kyung Dong Pharmaceutical Co. Ltd Total Liabilities
Kyung Dong Pharmaceutical Co. Ltd total liabilities. Based on the latest financial reports, Kyung Dong Pharmaceutical Co. Ltd (011040) has total liabilities worth ₩76.26 Billion KRW (≈ $51.68 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Kyung Dong Pharmaceutical Co. Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Total liabilities of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. This chart illustrates how Kyung Dong Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Kyung Dong Pharmaceutical Co. Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Kyung Dong Pharmaceutical Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Kyung Dong Pharmaceutical Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
XBP Europe Holdings Inc
NASDAQ:XBP
|
USA | $817.43 Million |
|
HusCompagniet AS
CO:HUSCO
|
Denmark | Dkr1.81 Billion |
|
Inseego Corp
NASDAQ:INSG
|
USA | $120.95 Million |
|
Welspun Investments and Commercials Limited
NSE:WELINV
|
India | Rs909.56 Million |
|
Global Education Limited
NSE:GLOBAL
|
India | Rs135.55 Million |
|
Heubach Colorants India Limited
NSE:HEUBACHIND
|
India | Rs1.91 Billion |
|
Vaziva Sa
PA:ALVAZ
|
France | €10.65 Million |
|
Talga Group Ltd
F:TGX
|
Germany | €5.87 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Kyung Dong Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Kyung Dong Pharmaceutical Co. Ltd.
Liquidity & Leverage Metrics
Kyung Dong Pharmaceutical Co. Ltd Total Liabilities Ratios Explained
Kyung Dong Pharmaceutical Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kyung Dong Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
The table below shows the annual total liabilities of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩93.02 Billion ≈ $63.04 Million |
+12.33% |
| 2024-12-31 | ₩82.81 Billion ≈ $56.12 Million |
+28.40% |
| 2023-12-31 | ₩64.49 Billion ≈ $43.71 Million |
+21.06% |
| 2022-12-31 | ₩53.27 Billion ≈ $36.10 Million |
+65.69% |
| 2021-12-31 | ₩32.15 Billion ≈ $21.79 Million |
+10.09% |
| 2020-12-31 | ₩29.21 Billion ≈ $19.79 Million |
-52.03% |
| 2019-12-31 | ₩60.88 Billion ≈ $41.26 Million |
+32.14% |
| 2018-12-31 | ₩46.08 Billion ≈ $31.23 Million |
+51.20% |
| 2017-12-31 | ₩30.47 Billion ≈ $20.65 Million |
+6.69% |
| 2016-12-31 | ₩28.56 Billion ≈ $19.36 Million |
+1.01% |
| 2015-12-31 | ₩28.28 Billion ≈ $19.16 Million |
-24.09% |
| 2014-12-31 | ₩37.25 Billion ≈ $25.24 Million |
+18.80% |
| 2013-12-31 | ₩31.35 Billion ≈ $21.25 Million |
-11.62% |
| 2012-12-31 | ₩35.48 Billion ≈ $24.04 Million |
+1.06% |
| 2011-12-31 | ₩35.10 Billion ≈ $23.79 Million |
-- |
About Kyung Dong Pharmaceutical Co. Ltd
Kyung Dong Pharmaceutical Co., Ltd. produces and sells specialized and general medicines in South Korea. It offers prescription medicines for liver therapy, antispasmodic, antidiabetic, antiviral, corticosteroid, androgen alopecia, muscle relaxant, antimigraine, vitamin, antifungal, endocrinal, urology, antibacterial, cardiovascular, pain/inflammation, smoking cessation aid, gastrointestinal, ant… Read more